References
- Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 2010; 11:607 - 620; PMID: 20683471; http://dx.doi.org/10.1038/nrm2950
- Ooi SK, Bestor TH. The colorful history of active DNA demethylation. Cell 2008; 133:1145 - 1148; PMID: 18585349; http://dx.doi.org/10.1016/j.cell.2008.06.009
- Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M. DNA methylation is a reversible biological signal. Proc Natl Acad Sci USA 1999; 96:6107 - 6112; PMID: 10339549; http://dx.doi.org/10.1073/pnas.96.11.6107
- Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 2003; 4:235 - 240; PMID: 12548284; http://dx.doi.org/10.1038/ni887
- D'Alessio AC, Weaver IC, Szyf M. Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes. Mol Cell Biol 2007; 27:7462 - 7474; PMID: 17709385; http://dx.doi.org/10.1128/MCB.01120-07
- Imamura T, Kerjean A, Heams T, Kupiec JJ, Thenevin C, Paldi A. Rapid CpG and non-CpG methylation turnover of Peg/Mest in the mouse oocyte and pre-implantation embryo. J Biol Chem 2005; 280:20171 - 20175; PMID: 15778220; http://dx.doi.org/10.1074/jbc.M501749200
- Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. Demethylation of the zygotic paternal genome. Nature 2000; 403:501 - 502; PMID: 10676950; http://dx.doi.org/10.1038/35000656
- Kangaspeska S, Stride B, Métivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, et al. Transient cyclical methylation of promoter DNA. Nature 2008; 452:112 - 115; PMID: 18322535; http://dx.doi.org/10.1038/nature06640
- Métivier R, Gallais R, Tiffoche C, Le Péron C, Jurkowska RZ, Carmouche RP, et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008; 452:45 - 50; PMID: 18322525; http://dx.doi.org/10.1038/nature06544
- Arányi T, Páldi A. The constant variation: DNA methylation changes during preimplantation development. FEBS Lett 2006; 580:6521 - 6526; PMID: 17134704; http://dx.doi.org/10.1016/j.febslet.2006.11.018
- Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, et al. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 2007; 6:515 - 523; PMID: 17559502; http://dx.doi.org/10.1111/j.1474-9726.2007.00306.x
- Glover AB, Leyland-Jones B. Biochemistry of azacitidine: a review. Cancer Treat Rep 1987; 71:959 - 964; PMID: 2443243
- Veselý J, Cihák A. Incorporation of a potent antileukemic agent, 5-aza-2′-deoxycytidine, into DNA of cells from leukemic mice. Cancer Res 1977; 37:3684 - 3689; PMID: 71199
- Lim HW, Iwatani M, Hattori N, Tanaka S, Yagi S, Shiota K. Resistance to 5-aza-2′-deoxycytidine in genic regions compared to non-genic repetitive sequences. J Reprod Dev 2010; 56:86 - 93; PMID: 19996551; http://dx.doi.org/10.1262/jrd.20247
- Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ, Hornby DP. Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol 2002; 321:591 - 599; PMID: 12206775; http://dx.doi.org/10.1016/S0022-2836(02)00676-9
- Kok RM, Smith DE, Barto R, Spijkerman AM, Teerlink T, Gellekink HJ, et al. Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects. Clin Chem Lab Med 2007; 45:903 - 911; PMID: 17617036; http://dx.doi.org/10.1515/CCLM.2007.137